ALB and clostridium difficile infection: The effect of fidaxomicin compared with vancomycin remained similar after adjustment for important baseline cofactors, including age, past CDI, number of unformed bowel movements, albumin level, white blood cell count, and creatinine level (relapse P < .001; reinfection P < .07).